MENU
+Compare
WUXIF
Stock ticker: OTC
AS OF
Jan 13 closing price
Price
$15.00
Change
+$1.40 (+10.29%)
Capitalization
44.96B

WUXIF stock forecast, quote, news & analysis

Wuxi AppTec Co Ltd provides a portfolio of research and manufacturing services throughout the discovery, development, and manufacturing spectrum for small molecule drugs, development of computer software and databases as well as consulting services for combinatorial chemistry and pharmaceuticals... Show more

WUXIF
Daily Signal:
Gain/Loss:
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
Interact to see
Advertisement
A.I.Advisor
a Summary for WUXIF with price predictions
Jan 13, 2026

WUXIF sees its Stochastic Oscillator climbs out of oversold territory

On January 13, 2026, the Stochastic Oscillator for WUXIF moved out of oversold territory and this could be a bullish sign for the stock. Traders may want to buy the stock or buy call options. Tickeron's A.I.dvisor looked at 24 instances where the indicator left the oversold zone. In of the 24 cases the stock moved higher in the following days. This puts the odds of a move higher at over .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for WUXIF just turned positive on December 08, 2025. Looking at past instances where WUXIF's MACD turned positive, the stock continued to rise in of 22 cases over the following month. The odds of a continued upward trend are .

WUXIF moved above its 50-day moving average on January 13, 2026 date and that indicates a change from a downward trend to an upward trend.

Bearish Trend Analysis

The RSI Oscillator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.

The Aroon Indicator for WUXIF entered a downward trend on December 23, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.399) is normal, around the industry mean (13.332). P/E Ratio (20.000) is within average values for comparable stocks, (127.018). WUXIF's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.939). Dividend Yield (0.009) settles around the average of (0.016) among similar stocks. P/S Ratio (6.743) is also within normal values, averaging (12.980).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. WUXIF’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. WUXIF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock better than average.

A.I.Advisor
published Dividends

WUXIF paid dividends on June 17, 2021

Wuxi Apptec Co Ltd. WUXIF Stock Dividends
А dividend of $0.44 per share was paid with a record date of June 17, 2021, and an ex-dividend date of May 28, 2021. Read more...
A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are IQVIA Holdings (NYSE:IQV), Illumina (NASDAQ:ILMN), Exact Sciences Corp (NASDAQ:EXAS), Guardant Health (NASDAQ:GH).

Industry description

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

Market Cap

The average market capitalization across the Medical Specialties Industry is 13.12B. The market cap for tickers in the group ranges from 27 to 3.82T. MKYSF holds the highest valuation in this group at 3.82T. The lowest valued company is FOGCF at 27.

High and low price notable news

The average weekly price growth across all stocks in the Medical Specialties Industry was 2%. For the same Industry, the average monthly price growth was 4%, and the average quarterly price growth was 44%. AVCRF experienced the highest price growth at 68%, while TDSGF experienced the biggest fall at -25%.

Volume

The average weekly volume growth across all stocks in the Medical Specialties Industry was -6%. For the same stocks of the Industry, the average monthly volume growth was 15% and the average quarterly volume growth was -11%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 50
P/E Growth Rating: 68
Price Growth Rating: 51
SMR Rating: 80
Profit Risk Rating: 90
Seasonality Score: 10 (-100 ... +100)
View a ticker or compare two or three
WUXIF
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
N/A
Address
288 Fute Zhong Road
Phone
+86 2150461111
Employees
44361
Web
https://www.wuxiapptec.com